4.6 Article

Calnexin Deficiency Leads to Dysmyelination

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 285, Issue 24, Pages 18928-18938

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M110.107201

Keywords

-

Funding

  1. National Institutes of Health [EYEY008768, F31AG032176]
  2. Canadian Institutes of Health Research [MOP-15291, MOP-8659, MOP-86470]
  3. Swiss National Science Foundation
  4. Retina Research Foundation
  5. Alberta Innovates-Health Solutions
  6. March of Dimes
  7. Davey Fund for Brain Research
  8. Multiple Sclerosis Society of Canada
  9. Heart and Stroke Foundation of Canada
  10. Membrane Protein Cardiovascular Disease Training Program

Ask authors/readers for more resources

Calnexin is a molecular chaperone and a component of the quality control of the secretory pathway. We have generated calnexin gene-deficient mice (cnx(-/)) and showed that calnexin deficiency leads to myelinopathy. Calnexin-deficient mice were viable with no discernible effects on other systems, including immune function, and instead they demonstrated dysmyelination as documented by reduced conductive velocity of nerve fibers and electron microscopy analysis of sciatic nerve and spinal cord. Myelin of the peripheral and central nervous systems of cnx(-/-) mice was disorganized and decompacted. There were no abnormalities in neuronal growth, no loss of neuronal fibers, and no change in fictive locomotor pattern in the absence of calnexin. This work reveals a previously unrecognized and important function of calnexin in myelination and provides new insights into the mechanisms responsible for myelin diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available